drugset / Trial / NCT00463801
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults
Timeline
- Start
- 2007-01
- Primary completion
- 2007-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daptomycin | Other / unclassified | 4 mg/kg | Intravenous |